23 Jul, 2026
According to Straits Research, the global hemp-derived CBD oil market size was valued at $2.91 billion in 2025 and is projected to grow from $3.56 billion in 2026 to $17.82 billion by 2034 at a CAGR of 22.3% during the forecast period 2026–2034.
Hemp-derived CBD oil is a natural substance extracted from the hemp plant, a type of Cannabis sativa that contains very low levels of THC (less than 0.3%). It is rich in cannabidiol (CBD), a non-intoxicating compound known for its potential health advantages, including easing anxiety, pain, and inflammation. Unlike CBD sourced from marijuana, hemp-based CBD is legal in many areas due to its negligible THC content. This oil is widely incorporated into wellness products such as tinctures, capsules, and creams, supporting relaxation and overall well-being without causing a psychoactive effect.
A key aspect propelling the growth of the global hemp-derived CBD oil market is the increasing consumer focus on health and wellness. CBD oil is gaining popularity as a natural remedy for managing issues such as anxiety, chronic pain, and insomnia. Individuals seeking holistic, plant-based solutions are increasingly turning to CBD products for both preventive care and therapeutic relief. This trend is particularly noticeable among middle-aged and older adults, who are drawn to non-pharmaceutical alternatives that are perceived to have fewer side effects.
This evidence reinforces the growing global trend toward wellness-driven, natural health solutions.
Research and development (R&D) presents a significant growth opportunity in the global hemp-derived CBD oil market, driving product innovation and supporting the validation of therapeutic claims. As scientific exploration into cannabinoids deepens, companies are ramping up investments in clinical research and advanced technologies to develop more precise and effective CBD formulations.
Ongoing R&D efforts not only help build consumer confidence but also facilitate the regulatory approval process, enabling wider market access and expanding the potential uses of CBD in the healthcare and wellness sectors.
North America maintains a leading position in the global hemp-derived CBD oil market, fueled by favorable regulatory policies and strong consumer awareness. The market in the United States has experienced prominent growth, particularly after the passage of the 2018 Farm Bill, which legalized industrial hemp and opened the door for the manufacturing and distribution of hemp-derived CBD products. Major players such as Charlotte's Web and CBDistillery have broadened their product ranges to include tinctures, edibles, and topicals, appealing to health-conscious consumers. The increasing recognition of CBD's potential benefits, such as alleviating pain, reducing anxiety, and enhancing sleep, has further driven market demand.
sales@straitsresearch.com